Health Canada drug identification number

DIN 02246962 — PYLERA 40 MG; 125 MG; 125 MG

PYLERA is a capsule of Bismuth Oxide / Tetracycline / Metronidazole marketed by LABORATOIRES JUVISE PHARMACEUTICALS. The full Bismuth Oxide / Tetracycline / Metronidazole monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02246962
Brand name
PYLERA
Strength
40 MG; 125 MG; 125 MG
Dosage form
CAPSULE
Route
ORAL
Manufacturer
LABORATOIRES JUVISE PHARMACEUTICALS
Health Canada status
MARKETED
Drug class
Combination antibacterial regimen for Helicobacter pylori eradication (bismuth compound with a tetracycline antibiotic and a nitroimidazole)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.